Financials data is unavailable for this security.
View more
Year on year Lexeo Therapeutics Inc 's revenues fell -100.00% from 654.00k to 0.00. has fallen 12.01% from a loss of 59.28m to a larger loss of 66.39m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -60.10% |
---|---|
Return on equity | -724.04% |
Return on investment | -68.82% |
More ▼
Cash flow in USDView more
In 2023, Lexeo Therapeutics Inc increased its cash reserves by 54.76%, or 44.13m. Cash Flow from Financing totalled 103.79m or -- of revenues. In addition the company used 59.50m for operations while cash used for investing totalled 165.00k.
Cash flow per share | -2.78 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.99 |
---|---|
Tangible book value per share | 4.99 |
More ▼
Balance sheet in USDView more
Current ratio | 9.38 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0098 |
---|---|
Total debt/total capital | 0.0097 |
More ▼